How much funding has VYRIAD INC raised?

VYRIAD INC has raised $95.0M in total funding, most recently a Series B round.

Who are VYRIAD INC's investors?

VYRIAD INC's investors include Harry Stine, Mayo Clinic, Mirae Asset, Regeneron Pharmaceuticals.

When was VYRIAD INC founded?

VYRIAD INC was founded in 2017.

Where is VYRIAD INC headquartered?

VYRIAD INC is headquartered in ROCHESTER, Minnesota, United States.

What industry is VYRIAD INC in?

VYRIAD INC operates in Biotech, Oncology.

How many employees does VYRIAD INC have?

VYRIAD INC has 11-50 employees.

VYRIAD INC

Where Therapies Go Viral

ROCHESTER, United States · Founded 2017 · $95.0M raised

Biotech

Oncology

Headquarters: ROCHESTER, Minnesota
Employees: 11–50
Founded: 2017
Business Model: B2B

Website: vyriad.com
Total Funding: $95.0M
Last Round: $85.0M Series BDec 2025
Rounds: 2

About

Vyriad is a clinical-stage biotechnology company founded by Mayo Clinic scientists developing engineered virus platforms for oncolytic virotherapy, in vivo gene therapy, and gene editing. The company's VSV and measles virus-based therapies are in Phase 1-2 clinical trials across multiple cancer types, with an ongoing strategic collaboration with Regeneron Pharmaceuticals.

Summary

VYRIAD INC is a Biotech company based in ROCHESTER, United States, founded in 2017. It has raised $95.0M in total across 2 rounds, most recently a $85.0M Series B round in Dec 2025. Investors include Harry Stine, Mayo Clinic and Mirae Asset.

LinkedIn X (Twitter)